Last reviewed · How we verify
NCT03499080
Medication Free Treatment: Characteristics, Justification and Outcome
trial testing Medication free treatment in Mental Illness in 183 participants. Status unknown.
1 April 2023
Quick facts
| Lead sponsor | University Hospital, Akershus |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 183 |
| Start date | 14 May 2018 |
| Primary completion | 1 April 2023 |
| Estimated completion | 1 April 2023 |
| Sites | 2 locations across Norway |
Drugs / interventions tested
- Medication free treatment
- Treatment as usual Myrvegen
- Treatment as usual Åråsen
Conditions studied
- Mental Illness — all drugs for Mental Illness →
Sponsor
University Hospital, Akershus
Who can join
Adults 18 to 100, any sex, with Mental Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In 2015 the Norwegian government, after initiative from user organizations, decided to implement medication free inpatient treatment units. The goal is to secure real options to medication for psychiatric illness, and to gather experiences with medication free options. Freedom of choice is a main concern. The projects main aim is to study the outcome of medication free treatments of mental illness compared to treatment as usual, as well as characteristics of the treatment and the treatment population and why patients choose this treatment. Hereunder we aim to document who asks for these kinds of services and why, what kind of treatment they get, how they experience it, and how they respond to this kind of treatment. An important part will be to document whether the goal of increased freedom of choice between real treatment options is fulfilled. Research questions 1. Does medication free treatment differ from treatment as usual? Are there any unique characteristics of the patient group who asks for this kind of treatment? What kind of treatment do they receive during their stay? How do they experience this treatment in comparison to treatment as usual? How is this in relation to the goals about increased freedom of choice? Does use of medication change during and/or after medication free treatment? 2. Why do patients choose medication free treatment? What are their reasons? What experiences lead to this wish? 3. What is the outcome of medication free treatment compared to treatment as usual?
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Why Service Users Choose Medication-Free Psychiatric Treatment: A Mixed-Method Study of User Accounts.
Standal K, Solbakken OA, Rugkåsa J, Martinsen AR, et al · · 2021 · cited 12× · PMID 34326632 · DOI 10.2147/ppa.s308151 -
Medication-Free Treatment in Mental Health Care How Does It Differ from Traditional Treatment?
Standal K, Solbakken OA, Rugkåsa J, Halvorsen MS, et al · · 2024 · cited 4× · PMID 38327730 · DOI 10.2147/ppa.s435610 -
Are People Worse Off in a Mental Health Treatment Paradigm Where Medication Is Deemphasised? A Naturalistic Noninferiority Trial of an Initiative to Improve Patient Choice.
Standal K, Solbakken OA, Šaltytė Benth J, Abbass A, et al · · 2025 · PMID 41277153 · DOI 10.1177/00207640251390930 -
Medication-free treatment in mental health care. How does it differ from traditional treatment?
Standal K, Solbakken OA, Rugkåsa J, Halvorsen MS, et al · · 2023 · DOI 10.21203/rs.3.rs-3038199/v2
Verify or expand the search:
- PubMed search for NCT03499080
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Illness
Currently open trials in the same condition.
- NCT07396623 — Validation of French PHQ-4 and PC-PTSD-5 Screening Scales · recruiting
- NCT05776316 — Harm Reduction Services · NA · recruiting
- NCT04881084 — Exploring Empathy and Compassion Using Digital Narratives · NA · recruiting
- NCT06290648 — Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings · NA · active not recruiting
- NCT06315114 — A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders · NA · recruiting
Other University Hospital, Akershus trials
Trials by the same sponsor.
- NCT06865027 — The Effect of Arterial Carbon Dioxide Levels on Cerebral Blood Flow and Cerebral Autoregulation in the Steep Trendelenbu · NA · enrolling by invitation
- NCT06721754 — Diabetes Related Foot Ulcers with Negative Pressure Wound Therapy · NA · recruiting
- NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting
- NCT06576752 — Management of Patients with Heart Failure At Home After Hospital Discharge · NA · recruiting
- NCT06032715 — Brief Intervention for Sleep Medication Misuse Among Elderly · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03499080 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Akershus
- Last refreshed: 29 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03499080.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing